FDA Inspection 800207 — Midwest Center For Reproductive Health
The FDA completed an inspection of Midwest Center For Reproductive Health on Sep 19, 2012 in Maple Grove, MN. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Sep 19, 2012
- Fiscal Year
- 2012
- Product Type
- Biologics
- Project Area
- Human Cellular, Tissue, and Gene Therapies
- Location
- Maple Grove, MN (United States)